Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inflazyme to commence phase Ib studies with new oral asthma therapy

Oct. 18, 1999

Anti-IgE MAb improves quality of life in allergy sufferers

Oct. 15, 1999

Treatment of complex bronchopulmonary disorders in pediatric patients with polyoxidonium

Oct. 15, 1999

SciClone broadens program for cystic fibrosis therapy

Oct. 15, 1999

Urodilatin: a novel treatment approach for patients with moderate to severe asthma

Oct. 14, 1999

Ariflo is a promising new treatment for COPD

Oct. 14, 1999

New bronchial therapeutics in the Byk Gulden pipeline

Oct. 14, 1999

New PKC inhibitors in development at AstraZeneca

Oct. 14, 1999

Preclinical, early clinical results indicate good efficacy and safety of D-4418

Oct. 13, 1999

Glaxo Wellcome receives approval in Germany for Flixotide in COPD

Oct. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...